Renowned scientists in the field of lipid research will lead a symposium entitled High Density Lipoproteins and Coronary Heart Disease on Saturday, November 7, 1998 in Dallas, TX. Scientists will review the hypothesis that low levels of high-density lipoprotein (HDL) cholesterol are a risk for coronary heart disease; discuss metabolic disorders that result in this condition; and evaluate treatment options.

The symposium, accredited by Continuing Medical Education at The Johns Hopkins University School of Medicine, will include presentations by:

• Ernst Schaefer, MD, chief, Lipid Metabolism Laboratory, USDA Human Nutrition Research Center at Tufts University
  
• H. Bryan Brewer, MD, chief, Molecular Diseases Branch, National Heart, Lung, and Blood Institute, National Institutes of Health
  
• Moti Kashyup, MD, director, Cholesterol Center, Veterans Affairs Medical Center
  
• John Guyton, MD, director, Duke Lipid Clinic, Duke University Medical Center
  
• Hanna Rubins, MD, associate professor of medicine, University of Minnesota School of Medicine. Dr. Rubins, the Lead Investigator for the High-Density Lipoprotein Intervention Trials (HIT), will be presenting data from HIT on Wednesday, November 11 at 1:00 pm during the American Heart Association Conference.

'"/>

Contact: Karen Peart
k.peart@noonanrusso.com
212-696-4455 ext.343
Noonan/Russo Communications
15-Oct-1998